Ramipril improves walking ability of PAD patients, study finds

02/6/2013 | HealthDay News

Researchers followed 212 people with peripheral artery disease and found that those who received the blood pressure drug ramipril walked 4 minutes longer on treadmill and got an extra 75 seconds of pain-free walking, on average, than those who took placebo. The improvement may sound relatively small but it surpasses the benefits of two FDA-approved drugs intended to improve PAD patients' walking ability, a researcher said. The findings were published in the Journal of the American Medical Association.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ